Back to Search
SYSYLIA MENA, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1457560765Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
050820(NY)
Research & Publications (12)
Long-term follow up of sustained viral response after treatment of hepatitis C with pegylated interferon alpha-2a in hemodialysis patients.
PMID 19440994·Int J Artif Organs·2009
3-trial
Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism.
PMID 18852136·Mol Cancer Ther·2008
7-preclinical
Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
PMID 18067041·Ren Fail·2007
3-trial
Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
PMID 17473197·Clin Cancer Res·2007
7-preclinical
Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma.
PMID 17135264·J Biol Chem·2007
7-preclinical
Oral ulcers produced by mycophenolate mofetil in two liver transplant patients.
PMID 17445557·Transplant Proc·2007
5-case
Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy.
PMID 16263711·J Biol Chem·2006
7-preclinical
A wellness class for inpatients with psychotic disorders.
PMID 16432442·J Psychiatr Pract·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6 E 32ND ST, 5TH FLOOR
NEW YORK, NY 10016 - Phone
- (212) 213-5570
Quick Facts
- NPI
- 1457560765
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 12
Are you this provider?
Claim Your Profile